---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-296398"
form_type: "8-K"
ticker: "NUVB"
cik: "0001811063"
company_name: "Nuvation Bio Inc."
filed_at: "2026-07-06T21:15:46+00:00"
generated_at: "2026-07-06T21:18:03.618467+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nuvation Bio completes full greenshoe, raising $287.5M in convertible notes

## Summary
- Underwriters exercised full over-allotment for additional $37.5M of 0.75% Convertible Senior Notes due 2032.
- Total aggregate principal amount of Notes sold: $287.5M; estimated net proceeds ~$277.6M.
- Net proceeds used to pay $2.2M for additional capped call transactions; remainder for general corporate purposes.
- Capped call transactions have cap price of $10.4580 per share, an 80% premium over June 25 closing price.

## SEC filing metadata
- accession: 0001193125-26-296398
- form_type: 8-K
- ticker: NUVB
- cik: 0001811063
- company_name: Nuvation Bio Inc.
- filed_at: 2026-07-06T21:15:46+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.03, 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811063/000119312526296398/0001193125-26-296398-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811063/000119312526296398/d136399d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-296398
- JSON: https://secwatch.observer/filing/0001193125-26-296398.json
- Plain text: https://secwatch.observer/filing/0001193125-26-296398.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.